3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Prostatic Neoplasms
12
Oropharyngeal Neoplasms
12
Head and Neck Neoplasms
7
Carcinoma, Squamous Cell
6
Nasopharyngeal Carcinoma
5
Esophageal Neoplasms
5
Rectal Neoplasms
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Oligodendroglioma
2
Myelodysplastic Syndromes
2
Lymphatic Metastasis
2
Leukemia, Myeloid, Acute
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Astrocytoma
2
Anus Neoplasms
2
Virus Diseases
1
Vaginal Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
7
trametinib
5
pembrolizumab
5
selpercatinib
4
dabrafenib
4
Specimen Handling
4
Nivolumab
4
cabozantinib
3
Iodine-131
3
spartalizumab
2
omipalisib
2
lenvatinib
2
durvalumab
2
binimetinib
2
Vemurafenib
2
Sorafenib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
CTLA-4 Antigen
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
tislelizumab
1
tipifarnib
1
sapanisertib
1
relatlimab
1
regorafenib
1
pertuzumab
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Thyroid Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT03669432
2022-05-02
THYRO-RT
Tata Memorial Hospital
Phase NA
Active not recruiting
72 enrolled